Stock screenerAll disclosures →
EDGAR →
CAPR
Conviction 8HealthcareScan · Mon, Aug 10, 2026CAPR$3.84-6.23%
ResistanceSupportVol 14Insider sell2
2
2
Vol MA14 8.09M
May 11May 28Jun 16Jul 6Jul 23Aug 10
WSB mentions · 24h changelatest +100.00%· 2 mentions
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price3.84
Change-6.23%
Gap-1.47%
Rel volume0.75×
Avg volume6.12M
Avg $ vol43.41M
SMA 2011.17
SMA 5020.00
SMA 20023.18
Price vs 50-80.82%
Price vs 200-83.46%
MA stackbearish
50/200 crossdeath · 6d
Supertrenddown · 9.05
RSI (14)24
MACD hist-0.27
MACD cross—
Stoch %K / %D19 / 20
ADX (14)50
+DI / −DI17 / 47
RSI divergence—
MACD divergence—
ATR %+48.02%
ADR %12.17%
52w high35.34
52w low0.0000
From 52w high-89.15%
Above 52w low—
New 52w highNo
SqueezeOff
Bollinger width280.47%
%B0.27
Donchian pos18.23%
Donchian high21.04
Donchian low0.0000
AVWAP (52w high)21.73
vs AVWAP high-82.35%
AVWAP (52w low)3.94
vs AVWAP low-2.74%
OBV trendDown
Chaikin MF (20)0.22
Today vs 20d0.75×
Avg vol (14d)8.09M
Avg vol (20d)6.12M
Avg $ vol (20d)43.41M
Market cap222.09M
RS 3m (vs SPY)-93.65%
RS 6m (vs SPY)-96.35%
RS line new highNo
Trend template2/8
Technical rank1.5
1 week-8.69%
1 month-82.17%
3 months-87.38%
6 months-84.49%
1 year-52.48%
YTD-86.45%
P/E-2.11
P/B0.80
P/S—
P/FCF-3.05
EPS-2.26
Div yield—
ROE-37.69%
ROA-32.19%
Debt/Eq—
Current8.42
EV/EBITDA-1.10
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth-159.58%
Price target4.38
Target upside14.21%
Analyst ratingHold
Institutional67.15%
Ent. value116.67M
Revenue2.26M
Net income-33.94M
Gross profit—
Free cash flow-72.72M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out57.91M
Employees231
ListedThu, Jun 20, 2002
Free float41.47M
Float %71.7%
Short interest15.58M
Days to cover10.8d
Short volume52.8%
Squeeze score74 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.59 vs −$0.55
Last surprise-7.3% miss
Setup gradeD
Conviction8 / 100
Pattern quality—
Tech rank1.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance30.56
Support9.32
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CAPR
No recent disclosed trades by Congress in CAPR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CAPR · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Krasney Karen EVP, GENERAL COUNSEL · Common Stock · 2026-06-25 | Sell | 24.1K | $732K | 2026-06-25 | 2026-06-29 |
Krasney Karen EVP, GENERAL COUNSEL · Stock Option (Right to Buy) · 2026-06-25 | Exercise | 24.1K | — | 2026-06-25 | 2026-06-29 |
Krasney Karen EVP, GENERAL COUNSEL · Common Stock · 2026-06-25 | Exercise | 24.1K | $77K | 2026-06-25 | 2026-06-29 |
Bergmann Anthony CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-25 | Exercise | 24.1K | $77K | 2026-06-25 | 2026-06-29 |
Bergmann Anthony CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-25 | Sell | 24.1K | $732K | 2026-06-25 | 2026-06-29 |
Bergmann Anthony CHIEF FINANCIAL OFFICER · Stock Option (Right to Buy) · 2026-06-25 | Exercise | 24.1K | — | 2026-06-25 | 2026-06-29 |
Bergmann Anthony CHIEF FINANCIAL OFFICER · Common Stock · 2026-06-24 | Sell | 400 | $12K | 2026-06-24 | 2026-06-24 |
Krasney Karen EVP, GENERAL COUNSEL · Stock Option (Right to Buy) · 2026-06-24 | Exercise | 400 | — | 2026-06-24 | 2026-06-24 |
Krasney Karen EVP, GENERAL COUNSEL · Common Stock · 2026-06-24 | Sell | 400 | $12K | 2026-06-24 | 2026-06-24 |
Krasney Karen EVP, GENERAL COUNSEL · Common Stock · 2026-06-24 | Exercise | 400 | $1K | 2026-06-24 | 2026-06-24 |
SEC filings
EDGAR filings in CAPR · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.